These share a common root cause, and, therefore, explain why we see leptin and insulin rising where obesity may not, or may rise later on, meaning that obesity was not the first mover in causing the rises in these biomarkers associated with chronic metabolic diseases. The gene discussed is INS; the disease is Obesity.